Novavax

HEADLINE_ROUNDUP

New York Times (News)

Headline Roundup

Johnson & Johnson Announces 1-Shot Vaccine is 66% Effective Against Moderate to Severe COVID-19

Johnson & Johnson’s Vaccine Offers Strong Protection but Fuels Concern About Variants

New York Times (News)

Johnson & Johnson Releases Single-Dose Vaccine Results

National Review (News)

Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19

NPR (Online News)

Balanced News about Novavax on AllSides

News from the Left

News from the Center

News from the Right

The CDC endorses Novavax, a more traditional COVID vaccine, for adults

NPR (Online News)

Novavax to cut 25% of global workforce

Fox Business

Novavax Covid vaccine clears key step on path to FDA authorization after committee endorses the shot

CNBC

Novavax CEO contends COVID vaccine is 'more stable' than alternatives, could reduce 'all disease'

Fox Business

Novavax says its COVID-19 vaccine is 90 percent effective

The Verge

Novavax COVID-19 vaccine recommended for approval by FDA advisory committee

Fox Business

Balanced News about Novavax from Across the Web Powered by Google. Enhanced by AllSides.

AllSides Balanced Search™ gives you recent news from outlets on all sides of the political spectrum so you can get the full picture.